Medical marijuana has stepped onto the global stage.

In what appears to be a first for marijuana and a major pharmaceutical company, a Novartis subsidiary and a Canadian producer of medical cannabis products have agreed to market them around the world.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

    • The medical marijuana container(s), for which there are several different types of containers, requires a protocol for the product to be safely stored using a unique approach to removing the oxygen from the vessels. Therefore, medical marijuana has a different way to store the products so the patients receive the purest form of their medication.

      From what I know, one is only able to purchase medical marijuana from a point of purchase location, the law requires a physician’s prescription, in the state where one resides.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy